Automated detection and control of controlled substances
Poster Jan 26, 2015
Joe Bradley, Ian Johns
Chemical and pharmaceutical companies routinely work with controlled substances, and must have adequate controls in place to meet the rapidly changing legislative requirements of the countries in which they operate.
This legislation is becoming increasingly complex and changes frequently as legislators try to keep up with emerging “legal highs”. Meanwhile, externalization of R&D means that compounds are synthesised, stored and transported across a multiplicity of geographies with differing laws.
In 2013 Scitegrity, in conjunction with the Pistoia Alliance and a number of pharmaceutical companies, developed Controlled Substances Squared (CS2) to address this challenge.
The system is able to scan large chemical libraries (millions of compounds) and determine whether a compound is considered as controlled in a country and what controls are needed.
Extracorporeal shockwave therapy accelerates motor axon regeneration despite a phenotypically mismatched environmentPoster
A femoral nerve defect model was adapted for the evaluation of proregenerative effects of extracorporeal shockwave therapy (ESWT). Functional evaluation, histology and qRT-PCR data show differences between sensory and motor-derived nerve transplants and a pro-regenerative effect of ESWT. These data provide evidence for the clinical application of ESWT after autologous nerve transplantation as a novel non-invasive method.READ MORE
Depressive Symptoms Related to Biological Markers of Immune Functioning among Young People with HIVPoster
Youth living with HIV (YLWH) are at risk for depression. This study aimed to identify trends in depressive symptoms for YLWH in a specialty-care clinic and follow up clinical treatment procedures.READ MORE
An Emerging Phenotype of Partial RAG 1/2 Deficiency Among Young Children with Autoimmunity and Viral InfectionsPoster
We describe the natural history of a cohort of 12 patients with confirmed partial RAG1/2 mutations and autoimmunity at a young age. We were seeking the link between viral infections and autoimmunity and tested candidate biomarkers that may reflect the underlying RAG1/2 protein deficiency.READ MORE
Comments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.Biopharma Cell Science Diagnostics Drug Discovery Informatics & Automation Proteomics & Metabolomics
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE